3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Lung Neoplasms
5
Triple Negative Breast Neoplasms
3
Neoplasms
3
Neoplasm Metastasis
3
Uterine Cervical Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Camurati-Engelmann Syndrome
2
Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Microsatellite Instability
1
Metastatic Solid Tumors
1
Mesothelioma, Malignant
1
Mesothelioma
1
Melanoma
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Gallbladder Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Cholangiocarcinoma
1
Brain Neoplasms
1
Biliary Tract Neoplasms
1
Interventions
sacituzumab govitecan
1
bintrafusp alfa protein, human
1
avelumab
1
Tomography, X-Ray Computed
1
Nivolumab
1
Ipilimumab
1
Electrocardiography
1
Echocardiography
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Metastatic Solid Tumors
×
bintrafusp alfa protein, human
×
Clear all
NCT04457778
2026-05-04
First in Human Study of M6223
EMD Serono
Phase 1
Completed
58 enrolled
38 charts